Journal Mobile Options
Table of Contents
Vol. 2, No. 1, 2011
Issue release date: January – April
Open Access Gateway
Case Rep Ophthalmol 2011;2:95–98
(DOI:10.1159/000326062)

Chronic Postoperative Endophthalmitis Caused by Actinomyces meyeri

Peponis V.G. · Chalkiadakis S.E. · Parikakis E.A. · Mitropoulos P.G.
‘Ophthalmiatreio’ Athens Eye Hospital, Second Eye Clinic, Athens, Greece
email Corresponding Author

Abstract

We report a female patient who developed chronic endophthalmitis after an uneventful cataract surgery. Cultures of aqueous humor and a vitreous sample showed positivity for Actinomyces meyeri. Intense anterior segment inflammation and a less evident impairment of the patient’s posterior segment led us to treat her vigorously with pars plana vitrectomy combined with intraocular and topical antibiotics. The patient achieved a good recovery of vision without the need to remove the intraocular lens and to add systemic drugs. To the best of our knowledge, this is the first reported case of an intraocular infection caused by A. meyeri after small-incision clear corneal phacoemulsification.


 Outline


 goto top of outline Key Words

  • Actinomyces meyeri
  • Cataract surgery
  • Chronic endophthalmitis
  • Pars plana vitrectomy
  • Topical antibiotics

 goto top of outline Abstract

We report a female patient who developed chronic endophthalmitis after an uneventful cataract surgery. Cultures of aqueous humor and a vitreous sample showed positivity for Actinomyces meyeri. Intense anterior segment inflammation and a less evident impairment of the patient’s posterior segment led us to treat her vigorously with pars plana vitrectomy combined with intraocular and topical antibiotics. The patient achieved a good recovery of vision without the need to remove the intraocular lens and to add systemic drugs. To the best of our knowledge, this is the first reported case of an intraocular infection caused by A. meyeri after small-incision clear corneal phacoemulsification.

Copyright © 2011 S. Karger AG, Basel


 goto top of outline Author Contacts

Vasileios G. Peponis, MD, MSc, PhD
‘Ophthalmiatreio’ Athens Eye Hospital, Second Eye Clinic
Eleftheriou Venizelou 26, GR–10672 Athens (Greece)
Tel. +30 210 362 3191, E-Mail pepbas@yahoo.com


 goto top of outline Article Information

Published online: March 5, 2011
Number of Print Pages : 4
Number of Figures : 3,


 goto top of outline Publication Details

Case Reports in Ophthalmology

Vol. 2, No. 1, Year 2011 (Cover Date: January - April)

Journal Editor: Loewenstein A. (Tel Aviv)
ISSN: NIL (Print), eISSN: 1663-2699 (Online)

For additional information: http://www.karger.com/COP


Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Abstract

We report a female patient who developed chronic endophthalmitis after an uneventful cataract surgery. Cultures of aqueous humor and a vitreous sample showed positivity for Actinomyces meyeri. Intense anterior segment inflammation and a less evident impairment of the patient’s posterior segment led us to treat her vigorously with pars plana vitrectomy combined with intraocular and topical antibiotics. The patient achieved a good recovery of vision without the need to remove the intraocular lens and to add systemic drugs. To the best of our knowledge, this is the first reported case of an intraocular infection caused by A. meyeri after small-incision clear corneal phacoemulsification.



 goto top of outline Author Contacts

Vasileios G. Peponis, MD, MSc, PhD
‘Ophthalmiatreio’ Athens Eye Hospital, Second Eye Clinic
Eleftheriou Venizelou 26, GR–10672 Athens (Greece)
Tel. +30 210 362 3191, E-Mail pepbas@yahoo.com


 goto top of outline Article Information

Published online: March 5, 2011
Number of Print Pages : 4
Number of Figures : 3,


 goto top of outline Publication Details

Case Reports in Ophthalmology

Vol. 2, No. 1, Year 2011 (Cover Date: January - April)

Journal Editor: Loewenstein A. (Tel Aviv)
ISSN: NIL (Print), eISSN: 1663-2699 (Online)

For additional information: http://www.karger.com/COP


Open Access License / Drug Dosage

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.